Selected research
Market Analysis & Forecast
Global Prothrombin Complex Market Analysis and Forecast 2026-2032
Market perspective
The global Prothrombin Complex market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prothrombin Complex is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Prothrombin Complex is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Prothrombin Complex is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Prothrombin Complex is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Prothrombin Complex include Takeda, Hualan Biological, Octapharma, Meheco Xinxing Pharma, Grifols and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Prothrombin Complex, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Prothrombin Complex, also provides the sales of main regions and countries. Of the upcoming market potential for Prothrombin Complex, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prothrombin Complex sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prothrombin Complex market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prothrombin Complex sales, projected growth trends, production technology, application and end-user industry.
Prothrombin Complex Segment by Company
Takeda
Hualan Biological
Octapharma
Meheco Xinxing Pharma
Grifols
CSL
Prothrombin Complex Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Prothrombin Complex Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Prothrombin Complex Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Prothrombin Complex in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prothrombin Complex sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Applications
- Hemophilia B
- Vitamin K Deficiency
- Others
Companies covered
- Takeda
- Hualan Biological
- Octapharma
- Meheco Xinxing Pharma
- Grifols
- CSL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Prothrombin Complex Market by Type
- 1.2.1 Global Prothrombin Complex Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 500 IU/Vial
- 1.2.3 600 IU/Vial
- 1.2.4 1000 IU/Vial
- 1.2.5 Others
- 1.3 Prothrombin Complex Market by Application
- 1.3.1 Global Prothrombin Complex Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hemophilia B
- 1.3.3 Vitamin K Deficiency
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Prothrombin Complex Market Dynamics
- 2.1 Prothrombin Complex Industry Trends
- 2.2 Prothrombin Complex Industry Drivers
- 2.3 Prothrombin Complex Industry Opportunities and Challenges
- 2.4 Prothrombin Complex Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Prothrombin Complex Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Prothrombin Complex Revenue by Region
- 3.2.1 Global Prothrombin Complex Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Prothrombin Complex Revenue by Region (2021-2026)
- 3.2.3 Global Prothrombin Complex Revenue by Region (2027-2032)
- 3.2.4 Global Prothrombin Complex Revenue Market Share by Region (2021-2032)
- 3.3 Global Prothrombin Complex Sales Estimates and Forecasts 2021-2032
- 3.4 Global Prothrombin Complex Sales by Region
- 3.4.1 Global Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Prothrombin Complex Sales by Region (2021-2026)
- 3.4.3 Global Prothrombin Complex Sales by Region (2027-2032)
- 3.4.4 Global Prothrombin Complex Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Prothrombin Complex Revenue by Manufacturers
- 4.1.1 Global Prothrombin Complex Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Prothrombin Complex Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Prothrombin Complex Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Prothrombin Complex Sales by Manufacturers
- 4.2.1 Global Prothrombin Complex Sales by Manufacturers (2021-2026)
- 4.2.2 Global Prothrombin Complex Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Prothrombin Complex Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Prothrombin Complex Sales Price by Manufacturers (2021-2026)
- 4.4 Global Prothrombin Complex Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Prothrombin Complex Manufacturers, Product Type & Application
- 4.7 Global Prothrombin Complex Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Prothrombin Complex Market CR5 and HHI
- 4.8.2 2025 Prothrombin Complex Tier 1, Tier 2, and Tier 3
5 Prothrombin Complex Market by Type
- 5.1 Global Prothrombin Complex Revenue by Type
- 5.1.1 Global Prothrombin Complex Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Prothrombin Complex Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Prothrombin Complex Revenue Market Share by Type (2021-2032)
- 5.2 Global Prothrombin Complex Sales by Type
- 5.2.1 Global Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Prothrombin Complex Sales by Type (2021-2032) & (Tons)
- 5.2.3 Global Prothrombin Complex Sales Market Share by Type (2021-2032)
- 5.3 Global Prothrombin Complex Price by Type
6 Prothrombin Complex Market by Application
- 6.1 Global Prothrombin Complex Revenue by Application
- 6.1.1 Global Prothrombin Complex Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Prothrombin Complex Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Prothrombin Complex Revenue Market Share by Application (2021-2032)
- 6.2 Global Prothrombin Complex Sales by Application
- 6.2.1 Global Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Prothrombin Complex Sales by Application (2021-2032) & (Tons)
- 6.2.3 Global Prothrombin Complex Sales Market Share by Application (2021-2032)
- 6.3 Global Prothrombin Complex Price by Application
7 Company Profiles
- 7.1 Takeda
- 7.1.1 Takeda Company Information
- 7.1.2 Takeda Business Overview
- 7.1.3 Takeda Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Takeda Prothrombin Complex Product Portfolio
- 7.1.5 Takeda Recent Developments
- 7.2 Hualan Biological
- 7.2.1 Hualan Biological Company Information
- 7.2.2 Hualan Biological Business Overview
- 7.2.3 Hualan Biological Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Hualan Biological Prothrombin Complex Product Portfolio
- 7.2.5 Hualan Biological Recent Developments
- 7.3 Octapharma
- 7.3.1 Octapharma Company Information
- 7.3.2 Octapharma Business Overview
- 7.3.3 Octapharma Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Octapharma Prothrombin Complex Product Portfolio
- 7.3.5 Octapharma Recent Developments
- 7.4 Meheco Xinxing Pharma
- 7.4.1 Meheco Xinxing Pharma Company Information
- 7.4.2 Meheco Xinxing Pharma Business Overview
- 7.4.3 Meheco Xinxing Pharma Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Meheco Xinxing Pharma Prothrombin Complex Product Portfolio
- 7.4.5 Meheco Xinxing Pharma Recent Developments
- 7.5 Grifols
- 7.5.1 Grifols Company Information
- 7.5.2 Grifols Business Overview
- 7.5.3 Grifols Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Grifols Prothrombin Complex Product Portfolio
- 7.5.5 Grifols Recent Developments
- 7.6 CSL
- 7.6.1 CSL Company Information
- 7.6.2 CSL Business Overview
- 7.6.3 CSL Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 CSL Prothrombin Complex Product Portfolio
- 7.6.5 CSL Recent Developments
8 North America
- 8.1 North America Prothrombin Complex Market Size by Type
- 8.1.1 North America Prothrombin Complex Revenue by Type (2021-2032)
- 8.1.2 North America Prothrombin Complex Sales by Type (2021-2032)
- 8.1.3 North America Prothrombin Complex Price by Type (2021-2032)
- 8.2 North America Prothrombin Complex Market Size by Application
- 8.2.1 North America Prothrombin Complex Revenue by Application (2021-2032)
- 8.2.2 North America Prothrombin Complex Sales by Application (2021-2032)
- 8.2.3 North America Prothrombin Complex Price by Application (2021-2032)
- 8.3 North America Prothrombin Complex Market Size by Country
- 8.3.1 North America Prothrombin Complex Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Prothrombin Complex Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Prothrombin Complex Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Prothrombin Complex Market Size by Type
- 9.1.1 Europe Prothrombin Complex Revenue by Type (2021-2032)
- 9.1.2 Europe Prothrombin Complex Sales by Type (2021-2032)
- 9.1.3 Europe Prothrombin Complex Price by Type (2021-2032)
- 9.2 Europe Prothrombin Complex Market Size by Application
- 9.2.1 Europe Prothrombin Complex Revenue by Application (2021-2032)
- 9.2.2 Europe Prothrombin Complex Sales by Application (2021-2032)
- 9.2.3 Europe Prothrombin Complex Price by Application (2021-2032)
- 9.3 Europe Prothrombin Complex Market Size by Country
- 9.3.1 Europe Prothrombin Complex Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Prothrombin Complex Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Prothrombin Complex Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Prothrombin Complex Market Size by Type
- 10.1.1 China Prothrombin Complex Revenue by Type (2021-2032)
- 10.1.2 China Prothrombin Complex Sales by Type (2021-2032)
- 10.1.3 China Prothrombin Complex Price by Type (2021-2032)
- 10.2 China Prothrombin Complex Market Size by Application
- 10.2.1 China Prothrombin Complex Revenue by Application (2021-2032)
- 10.2.2 China Prothrombin Complex Sales by Application (2021-2032)
- 10.2.3 China Prothrombin Complex Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Prothrombin Complex Market Size by Type
- 11.1.1 Asia Prothrombin Complex Revenue by Type (2021-2032)
- 11.1.2 Asia Prothrombin Complex Sales by Type (2021-2032)
- 11.1.3 Asia Prothrombin Complex Price by Type (2021-2032)
- 11.2 Asia Prothrombin Complex Market Size by Application
- 11.2.1 Asia Prothrombin Complex Revenue by Application (2021-2032)
- 11.2.2 Asia Prothrombin Complex Sales by Application (2021-2032)
- 11.2.3 Asia Prothrombin Complex Price by Application (2021-2032)
- 11.3 Asia Prothrombin Complex Market Size by Country
- 11.3.1 Asia Prothrombin Complex Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Prothrombin Complex Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Prothrombin Complex Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Prothrombin Complex Market Size by Type
- 12.1.1 SAMEA Prothrombin Complex Revenue by Type (2021-2032)
- 12.1.2 SAMEA Prothrombin Complex Sales by Type (2021-2032)
- 12.1.3 SAMEA Prothrombin Complex Price by Type (2021-2032)
- 12.2 SAMEA Prothrombin Complex Market Size by Application
- 12.2.1 SAMEA Prothrombin Complex Revenue by Application (2021-2032)
- 12.2.2 SAMEA Prothrombin Complex Sales by Application (2021-2032)
- 12.2.3 SAMEA Prothrombin Complex Price by Application (2021-2032)
- 12.3 SAMEA Prothrombin Complex Market Size by Country
- 12.3.1 SAMEA Prothrombin Complex Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Prothrombin Complex Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Prothrombin Complex Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Prothrombin Complex Value Chain Analysis
- 13.1.1 Prothrombin Complex Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Prothrombin Complex Production Mode & Process
- 13.2 Prothrombin Complex Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Prothrombin Complex Distributors
- 13.2.3 Prothrombin Complex Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst